Century Therapeutics, Inc. (IPSC)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreKey Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Dr. Brent Pfeiffenberger M.B.A., Pharm.D.
|
President, CEO & Chairman | 971.73k | -- | 1978 |
|
Dr. Gregory Russotti Ph.D.
|
Chief Technology & Manufacturing Officer | 789.96k | -- | 1967 |
|
Dr. Chad A. Cowan Ph.D.
|
Chief Scientific Officer | 760.54k | -- | 1972 |
|
Mr. Douglas Carr CPA
|
Senior VP of Finance & Operations, Principal Financial Officer and Secretary | -- | -- | -- |
|
Krista Kauppinen J.D., Ph.D.
|
VP, General Counsel & Head of Intellectual Property | -- | -- | -- |
|
Ms. Megan Bilson
|
Chief People Officer | -- | -- | -- |
|
Michael Naso Ph.D.
|
Senior VP of Cell Engineering | -- | -- | -- |
|
Ms. Elizabeth Devlin
|
VP & Head of Development | -- | -- | -- |
Century Therapeutics, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 78
Description
Century Therapeutics, Inc., a biotechnology company, engages in the development of allogeneic cell therapies for the treatment of solid tumor, hematological malignancies, and autoimmune diseases. Its lead product candidate is CNTY-813, an iPSC-derived beta islet cell replacement therapy engineered with Allo-Evasion 5.0 for the treatment of type 1 diabetes. The company is also involved in the development of CNTY-308, a CD19-targeted CD4+/CD8+ CAR-iT cell therapy engineered with Allo-Evasion 5.0 as a potential treatment for B-cell-mediated autoimmune diseases; and CNTY-101, an allogeneic, iPSC-derived CAR-iNK cell therapy with six precision gene edits engineered to express CD19 CAR, with Allo-Evasion 1.0 edits designed for the treatment of CD19 for B-cell mediated autoimmune diseases. Century Therapeutics, Inc. was incorporated in 2018 and is headquartered in Philadelphia, Pennsylvania.
Corporate Governance
Upcoming Events
November 12, 2026 at 1:30 PM UTC
Century Therapeutics, Inc. Earnings Date
